AUDIATMED
The computed 12-month bankruptcy probability of AUDIATMED is 0.3% (very low). The 2025 annual accounts show equity of €250k and a net result of €143k. Equity is growing by ~103% per year across the filed fiscal years. Its solvency ranks better than 69% of 2208 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €250k |
| Net result | €143k |
| Better than sector | 69% |
| Active | 3 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 78.3% | 58.2% | |
| Net result | €143k | €60k | |
| Equity | €250k | €74k | |
| Gross operating margin | €205k | €96k | |
| Total assets | €319k | €186k |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €205k |
| Net profit | €143k |
| Cash flow | €161k |
| Staff costs | - |
| Income taxes | €41k |
| Dividends | - |
| Total assets | €319k |
| Equity | €250k |
| Debt | €69k |
| of which ≤ 1y | €22k |
| of which > 1y | €48k |
| Working capital | €205k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 10.42 |
| Quick ratio | 10.42 |
| Working capital ratio | 64.1% |
| Solvency | 78.3% |
| Debt / equity | 0.28 |
| Long-term debt ratio | 0.19 |
| Interest coverage | 82.29 |
| Gross margin | - |
| Net margin | - |
| ROA | 44.8% |
| ROE | 57.2% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €319k |
| Fixed assets | 21/28 | €93k |
| Tangible fixed assets | 22/27 | €93k |
| Current assets | 29/58 | €226k |
| Amounts receivable within one year | 40/41 | €91k |
| Cash & bank | 54/58 | €81k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €319k |
| Equity | 10/15 | €250k |
| Contributions / capital | 10/11 | €3k |
| Reserves | 13 | €247k |
| Amounts payable | 17/49 | €69k |
| Amounts payable after one year | 17 | €48k |
| Amounts payable within one year | 42/48 | €22k |
| Trade debts payable within one year | 44 | €2k |
| Income statement | ||
| Gross operating margin | 9900 | €205k |
| Operating result | 9901 | €187k |
| Financial charges | 65 | €2k |
| Result before taxes | 9903 | €184k |
| Income taxes | 67/77 | €41k |
| Net result for the period | 9904 | €143k |
| Result to be appropriated | 9905 | €143k |
| NACE primary | Human health(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 26-07-2023 |
| Status | Active |
| Postal code | 1060 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21013B0386/00H018 | Brussels | 516 m² | 1 · 129 m² | 20.4 m · 6 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
10-04-2026 Act object · Seat change · Board meeting
- Act object: TRANSFERT DU SIEGE SOCIAL · AUDIATMED
- Seat change: new: Rue Antoine Breart 54 à 1060 SAINT-GILLES (Région Bruxelles-Capitale), old: Rue Egide Walschaerts 22 à 1060 Saint-Gilles, date: 2025-09-25 · AUDIATMED
- Filing: date: 2026-04-02, location: greffe du tribunal de l'entreprise francophone de Bruxelles · AUDIATMED
- Publication: date: 2026-04-10 · AUDIATMED
- Board meeting: date: 2025-09-25, location: Rue Egide Walschaerts 22 à 1060 Saint-Gilles · AUDIATMED
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Objet de l\u0027acte: TRANSFERT DU SIEGE SOCIAL",
"value": "TRANSFERT DU SIEGE SOCIAL",
"object": null,
"subject": "e1"
},
{
"type": "seat_change",
"quote": "Le si\u00E8ge social et l\u0027unit\u00E9 d\u0027\u00E9tablissement sont transf\u00E9r\u00E9s ce jour \u00E0 l\u0027adresse suivante: Rue Antoine Breart 54 \u00E0 1060 SAINT-GILLES (R\u00E9gion Bruxelles-Capitale).",
"value": {
"new": "Rue Antoine Breart 54 \u00E0 1060 SAINT-GILLES (R\u00E9gion Bruxelles-Capitale)",
"old": "Rue Egide Walschaerts 22 \u00E0 1060 Saint-Gilles",
"date": "2025-09-25"
},
"object": null,
"subject": "e1"
},
{
"type": "filing",
"quote": "D\u00E9pos\u00E9 / Re\u00E7u la 02 AVR, 2026 au gr:ffe d tribucreffee l\u0027entreprisa francophone de Bruxelles",
"value": {
"date": "2026-04-02",
"location": "greffe du tribunal de l\u0027entreprise francophone de Bruxelles"
},
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 10/04/2026 - Annexes du Moniteur belge",
"value": {
"date": "2026-04-10"
},
"object": null,
"subject": "e1"
},
{
"type": "board_meeting",
"quote": "L\u0027an 2025, le 25 septembre, au si\u00E8ge social \u00E0 Saint-Gilles, Rue Egide Walschaerts 22, s\u0027est r\u00E9uni l\u0027organe d\u0027administration de la soci\u00E9t\u00E9 AUDIATMED SRL afin de modifier le si\u00E8ge social de la soci\u00E9t\u00E9.",
"value": {
"date": "2025-09-25",
"location": "Rue Egide Walschaerts 22 \u00E0 1060 Saint-Gilles"
},
"object": null,
"subject": "e1"
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 1246,
"truncated": false,
"needs_verify": true
},
"entities": [
{
"id": "e1",
"kbo": "0804.310.439",
"kind": "company",
"name": "AUDIATMED",
"attrs": {
"new_seat": "Rue Antoine Breart 54 \u00E0 1060 SAINT-GILLES (R\u00E9gion Bruxelles-Capitale)",
"old_seat": "Rue Egide Walschaerts 22 \u00E0 1060 Saint-Gilles",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Charles AUDIAT",
"attrs": {
"role": "administrateur"
}
}
]
}31-07-2023 Incorporation of a new SRL
Technical details
{
"kind": "oprichting",
"seat": "1060 Saint-Gilles, Rue Egide Walschaerts 22/TM",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "AUDIAT Charles Jean Jacques",
"niss": null,
"address": "1060 Saint-Gilles, Rue Egide Walschaerts 22 /TM"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 2500,
"holder_person_name": "AUDIAT Charles Jean Jacques",
"is_subscriber_only": false,
"n_shares_subscribed": 250,
"amount_subscribed_eur": 2500,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 2500,
"subject_company": {
"kbo": "0804.310.439",
"name_full": "AUDIATMED",
"legal_form": "SRL"
},
"initial_directors": [],
"incorporation_date": "2023-07-19",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | AUDIATMED |